https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-50https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-502011-11-16 00:00:002021-11-15 16:57:44Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-10-04 / Int. J. Oncol. 2012 Jan;40(1):287-98https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-10-04 / Int. J. Oncol. 2012 Jan;40(1):287-982011-10-04 00:00:002021-11-15 16:58:12Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2011-09-01 17:28:532019-02-12 17:32:01Nobelpreis für Medizin 2011 für die Entdeckung grundlegender immunologischer Mechanismen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2011-06-28 17:30:112019-02-12 17:30:56Artikel in der WirtschaftsWoche: "Impfung gegen Krebs"
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-05-09 / Int. J. Oncol. 2011 Aug;39(2):493-504https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-05-09 / Int. J. Oncol. 2011 Aug;39(2):493-5042011-05-09 00:00:002021-11-15 16:58:35Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-29https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-292011-03-17 00:00:002021-11-15 16:59:03Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-12-01 / Int. J. Oncol. 2010 Dec;37(6):1439-52https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-12-01 / Int. J. Oncol. 2010 Dec;37(6):1439-522010-12-01 00:00:002021-11-15 16:59:47Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002010-11-01 / Int. J. Oncol. 2010 Nov;37(5):1203-17https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2010-11-01 / Int. J. Oncol. 2010 Nov;37(5):1203-172010-11-01 00:00:002021-11-15 17:00:11Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine
Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-50Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-10-04 / Int. J. Oncol. 2012 Jan;40(1):287-98Nobelpreis für Medizin 2011 für die Entdeckung grundlegender immunologischer Mechanismen
/in Externe Meldungen, IOZK Meldungen /von IOZKArtikel in der WirtschaftsWoche: „Impfung gegen Krebs“
/in Externe Meldungen /von IOZKImportant role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-05-09 / Int. J. Oncol. 2011 Aug;39(2):493-504Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-29Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-12-18 / Vaccine 2011 Feb;29(6):1185-93Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-12-01 / Int. J. Oncol. 2010 Dec;37(6):1439-52Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccine
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-11-01 / Int. J. Oncol. 2010 Nov;37(5):1203-17The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-08-13 / Vaccine 2010 Oct;28(42):6891-900